TransMedics Group, Inc.
TMDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $441,540 | $241,623 | $93,459 | $30,262 |
| % Growth | 82.7% | 158.5% | 208.8% | – |
| Cost of Goods Sold | $179,459 | $87,530 | $28,187 | $9,103 |
| Gross Profit | $262,081 | $154,093 | $65,272 | $21,159 |
| % Margin | 59.4% | 63.8% | 69.8% | 69.9% |
| R&D Expenses | $55,968 | $63,267 | $26,812 | $22,304 |
| G&A Expenses | $168,617 | $119,553 | $51,688 | $38,283 |
| SG&A Expenses | $168,617 | $119,553 | $69,897 | $38,283 |
| Sales & Mktg Exp. | $0 | $0 | $18,209 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $224,585 | $182,820 | $96,709 | $60,587 |
| Operating Income | $37,496 | -$28,727 | -$31,437 | -$39,428 |
| % Margin | 8.5% | -11.9% | -33.6% | -130.3% |
| Other Income/Exp. Net | -$1,716 | $2,056 | -$4,728 | -$4,751 |
| Pre-Tax Income | $35,780 | -$26,671 | -$36,165 | -$44,179 |
| Tax Expense | $316 | -$1,643 | $66 | $36 |
| Net Income | $35,464 | -$25,028 | -$36,231 | -$44,215 |
| % Margin | 8% | -10.4% | -38.8% | -146.1% |
| EPS | 1.07 | -0.77 | -1.23 | -1.6 |
| % Growth | 239% | 37.4% | 23.1% | – |
| EPS Diluted | 1.01 | -0.77 | -1.23 | -1.6 |
| Weighted Avg Shares Out | 33,230 | 32,517 | 29,557 | 27,617 |
| Weighted Avg Shares Out Dil | 35,217 | 32,517 | 29,557 | 27,617 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $12,500 | $900 | $0 |
| Interest Expense | $14,409 | $10,791 | $3,726 | $3,874 |
| Depreciation & Amortization | $19,758 | $8,177 | $3,478 | $1,817 |
| EBITDA | $69,947 | -$7,703 | -$28,961 | -$38,488 |
| % Margin | 15.8% | -3.2% | -31% | -127.2% |